Dr. Shireman is a professor and executive associate dean in the Texas A&M School of Medicine. She is the principal investigator of a National Institutes of Health (NIH) multi-center U01 grant developing predictive models for surgical outcomes including frailty and social risk factors. The goal is to use data to transform health care, influence federal policy and design financially sustainable care pathways improving outcomes for frail and low socioeconomic status patients. Her interests include predictive modeling, machine learning and simulation.Dr. Shireman serves on the advisory council for the National Center for Advancing Translational Sciences (NCATS) and Cures Acceleration Network (CAN) review board at the NIH. She was a member of the MACRA episode-based cost measure clinical subcommittee to develop measures for peripheral vascular disease management and chair of the clinical subcommittee workgroup for hemodialysis access creation.D. Shireman was a multi-principal investigator of the Institutional Clinical Translational Science Award (CTSA) at UT Health San Antonio (UTHSA) and South Texas Veterans Health Care System. She received multiple external awards from the NIH and the Veterans Administration for basic, translational and clinical research.Dr. Shireman earned a MD from Indiana University, a Master of Science in clinical investigation from UTHSA and MBA from the McCombs School of Business at the University of Texas at Austin. She is board-certified in general surgery, vascular surgery, clinical informatics and wound care.
